5 Stocks for Dividend Growth Investing in 2022

3. Amgen Inc. (NASDAQ:AMGN)

Dividend Yield as of January 24: 3.41%

Number of Years of Consistent Dividend Increases: 10

Number of Hedge Fund Holders: 52

Headquartered in California, Amgen Inc. (NASDAQ:AMGN) is one of the largest multinational biopharmaceutical companies in the world that uses recombinant DNA technology to create cures for autoimmune diseases and cancer. 

On December 3, Amgen Inc. (NASDAQ:AMGN) declared a $1.94 per share quarterly dividend, which is a 10.2% increase from the prior dividend of $1.76. The dividend will be paid on March 8, to shareholders of record on February 15. 

John Overdeck and David Siegel’s Two Sigma Advisors is the biggest Amgen Inc. (NASDAQ:AMGN) stakeholder as of Q3 2021, with 1.85 million shares worth roughly $394 million. Overall, 52 hedge funds in the third quarter database of Insider Monkey were bullish on Amgen Inc. (NASDAQ:AMGN), with stakes totaling $1.4 billion. 

Here is what ClearBridge Sustainability Leaders Strategy has to say about Amgen, Inc. (NASDAQ:AMGN) in its Q3 2021 investor letter:

“In health care, Amgen, a biotechnology company, has endured several pipeline setbacks recently, including a slow transition of its Lumakras treatment into first-line lung cancer, a slower than expected development of its treatment for myeloma as well as the company’s asthma treatment Tezepelumab missing its primary endpoint in a Phase III study. We remain positive on the stock, with Amgen’s investments in biosimilars and its pipeline part of our long-term thesis.”